Cancel
About Isaac Ro
Isaac Ro is a board member involved in advancing small molecule drug discovery, having played a key role in strategic appointments and collaborations.
Known information
Isaac Ro serves as a board member at a company focused on the discovery of small molecule therapeutics. His tenure has seen significant developments, including the appointment of Adrian Schreyer as Chief Technology Officer and Ryan Kruger as Chief Scientific Officer. Isaac Ro was instrumental in a multi-target collaboration aimed at discovering therapeutics for various indications. Under his guidance, the company also closed a $30 million Series A funding round led by Catalio, which is intended to advance a novel, directed evolution platform for drug discovery. The company is based at 20 Maguire Rd Suite 302, Lexington, MA 02421, and can be contacted at (978) 444-2649.
About Anagenex
Anagenex is a biotechnology company focused on advancing small molecule drug discovery through a novel, directed evolution platform, having recently closed a $30 million Series A funding round.
Report inaccurate information
